Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 18, 2022

Accession no.
0001209191-22-057945
Filed
Nov 18, 2022
Trade date
Sep 27-Oct 31, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 25 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.93K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 27, 2022Common StockPPurchaseAcquired+31$2.57+$79.6724,231Direct
Sep 28, 2022Common StockPPurchaseAcquired+31$2.52+$78.1224,262Direct
Sep 29, 2022Common StockPPurchaseAcquired+31$2.51+$77.8124,293Direct
Sep 30, 2022Common StockPPurchaseAcquired+31$2.61+$80.9124,324Direct
Oct 3, 2022Common StockPPurchaseAcquired+31$2.54+$78.7424,355Direct
Oct 4, 2022Common StockPPurchaseAcquired+31$2.61+$80.9124,386Direct
Oct 5, 2022Common StockPPurchaseAcquired+31$2.58+$79.9824,417Direct
Oct 6, 2022Common StockPPurchaseAcquired+31$2.65+$82.1524,448Direct
Oct 7, 2022Common StockPPurchaseAcquired+31$2.66+$82.4624,479Direct
Oct 10, 2022Common StockPPurchaseAcquired+31$2.53+$78.4324,510Direct
Oct 11, 2022Common StockPPurchaseAcquired+31$2.48+$76.8824,541Direct
Oct 12, 2022Common StockPPurchaseAcquired+31$2.49+$77.1924,572Direct
Oct 13, 2022Common StockPPurchaseAcquired+31$2.38+$73.7824,603Direct
Oct 14, 2022Common StockPPurchaseAcquired+31$2.31+$71.6124,634Direct
Oct 17, 2022Common StockPPurchaseAcquired+31$2.33+$72.2324,665Direct
Oct 18, 2022Common StockPPurchaseAcquired+31$2.46+$76.2624,696Direct
Oct 19, 2022Common StockPPurchaseAcquired+31$2.42+$75.0224,727Direct
Oct 20, 2022Common StockPPurchaseAcquired+31$2.44+$75.6424,758Direct
Oct 21, 2022Common StockPPurchaseAcquired+31$2.49+$77.1924,789Direct
Oct 24, 2022Common StockPPurchaseAcquired+31$2.38+$73.7824,820Direct
Oct 25, 2022Common StockPPurchaseAcquired+31$2.44+$75.6424,851Direct
Oct 26, 2022Common StockPPurchaseAcquired+31$2.42+$75.0224,882Direct
Oct 27, 2022Common StockPPurchaseAcquired+31$2.49+$77.1924,913Direct
Oct 28, 2022Common StockPPurchaseAcquired+31$2.52+$78.1224,944Direct
Oct 31, 2022Common StockPPurchaseAcquired+31$2.54+$78.7424,975Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)